Related Experiment Video
Updated: Jul 14, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Nonsense mediated decay factor UPF3B is associated with cMyBP-C haploinsufficiency in hypertrophic cardiomyopathy
Valentin Burkart1, Kathrin Kowalski1, Alina Disch1
1Institute for Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Insights
Hypertrophic cardiomyopathy (HCM) is linked to myosin binding protein C (cMyBP-C) gene mutations. UPF3B-dependent nonsense-mediated decay (NMD) at the Z-disc explains cMyBP-C haploinsufficiency in HCM patients.
Area of Science:
- Cardiovascular Genetics
- Molecular Biology
- Cell Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease, often caused by mutations in the MYBPC3 gene.
- Many MYBPC3 mutations result in premature termination codons (PTCs), leading to reduced functional myosin binding protein C (cMyBP-C) and haploinsufficiency, a likely driver of HCM.
- Distinguishing HCM-specific mechanisms from general hypertrophy is crucial, necessitating controls like aortic stenosis (AS).
Purpose of the Study:
- To investigate the molecular mechanisms underlying cMyBP-C haploinsufficiency in HCM patients with MYBPC3 truncation mutations.
- To determine if haploinsufficiency originates at the transcriptional, mRNA, or protein level.
- To identify specific cellular pathways involved in HCM pathogenesis related to MYBPC3 mutations.
Main Methods:
- Analysis of cardiac tissue from HCM patients with MYBPC3 truncation mutations (MYBPC3trunc) and AS patients, compared to donor controls.
- Assessment of transcriptional activity, mRNA, and protein expression levels.
- RNA-sequencing and Gene Set Enrichment Analysis (GSEA) to identify differentially expressed genes and pathways, focusing on nonsense-mediated decay (NMD) components.
- Immunolocalization studies to determine the subcellular localization of NMD factors (UPF1, UPF2, UPF3B) within sarcomeres.
Main Results:
- cMyBP-C haploinsufficiency in MYBPC3trunc HCM patients begins at the mRNA level, despite increased transcriptional activity due to hypertrophy.
- GSEA revealed upregulation of NMD pathway components in MYBPC3trunc patients.
- Up-frameshift protein UPF3B, an NMD regulator, was specifically upregulated in MYBPC3trunc patients but not in AS patients.
- UPF3B, unlike UPF1 and UPF2, was localized to sarcomeric Z-discs, the site of sarcomeric protein translation.
Conclusions:
- UPF3B-dependent nonsense-mediated decay (NMD) is a key mechanism establishing cMyBP-C haploinsufficiency in HCM.
- This NMD process occurs during the initial translation round at the sarcomeric Z-disc.
- These findings provide novel insights into the molecular pathogenesis of HCM driven by MYBPC3 mutations.
Abstract:
Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac disease. Up to 40% of cases are associated with heterozygous mutations in myosin binding protein C (cMyBP-C, MYBPC3). Most of these mutations lead to premature termination codons (PTC) and patients show reduction of functional cMyBP-C. This so-called haploinsufficiency most likely contributes to disease development. We analyzed mechanisms underlying haploinsufficiency using cardiac tissue from HCM-patients with truncation mutations in MYBPC3 (MYBPC3trunc). We compared transcriptional activity, mRNA and protein expression to donor controls. To differentiate between HCM-specific and general hypertrophy-induced mechanisms we used patients with left ventricular hypertrophy due to aortic stenosis (AS) as an additional control. We show that cMyBP-C haploinsufficiency starts at the mRNA level, despite hypertrophy-induced increased transcriptional activity. Gene set enrichment analysis (GSEA) of RNA-sequencing data revealed an increased expression of NMD-components. Among them, Up-frameshift protein UPF3B, a regulator of NMD was upregulated in MYBPC3trunc patients and not in AS-patients. Strikingly, we show that in sarcomeres UPF3B but not UPF1 and UPF2 are localized to the Z-discs, the presumed location of sarcomeric protein translation. Our data suggest that cMyBP-C haploinsufficiency in HCM-patients is established by UPF3B-dependent NMD during the initial translation round at the Z-disc.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Cardiomyopathy I: Introduction and Classification
Nuclear Export of mRNA

